
Thursday Feb 23, 2023
Review of 2022: M&A, Licensing and Fundraising
Listen as Fintan Walton, PharmaVentures’ CEO and Founder, reflects on this year’s deal trends in M&A, Licensing and Fundraising, considers the significant macroeconomic events, and offers insight into what impact they may have on the global pharma and biotech industry in 2023. Hosted by Adrian Dawkes.
No comments yet. Be the first to say something!